Literature DB >> 6249334

Centrally acting drugs in antihypertensive therapy.

C T Dollery, D S Davies.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6249334      PMCID: PMC1430126          DOI: 10.1111/j.1365-2125.1980.tb04898.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Guanfacine produces differential effects in frontal cortex compared with striatum: assessed by phMRI BOLD contrast.

Authors:  Neil Easton; Yasmene B Shah; Fiona H Marshall; Kevin C Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2006-10-03       Impact factor: 4.530

2.  Acute Cannabigerol Administration Lowers Blood Pressure in Mice.

Authors:  Victoria L Vernail; Sarah S Bingaman; Yuval Silberman; Wesley M Raup-Konsavage; Kent E Vrana; Amy C Arnold
Journal:  Front Physiol       Date:  2022-05-09       Impact factor: 4.755

3.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 4.  Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

5.  The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.

Authors:  A D Struthers; M J Brown; E F Adams; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

6.  Comparison of the actions of centrally and peripherally administered clonidine and guanfacine in the rabbit: investigation of the differences.

Authors:  N D Barber; J L Reid
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.